Besides eIF4E, other eIFs such as eIF2β [27], eIF3b [28], eIF3m [29], eIF4G1 [30] and eIF6 [31] are also validated abnormal activity in NSCLC. This evidence concerns the gene EIF4E and non-small cell lung carcinoma.